Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc.
Charles Kwok-Fung Chiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc., Charles Kwok-Fung ChiufiledCriticalPfizer Products Inc.
Priority claimed from CA002308922Aexternal-prioritypatent/CA2308922C/en
Publication of CA2555051A1publicationCriticalpatent/CA2555051A1/en
Application grantedgrantedCritical
Publication of CA2555051CpublicationCriticalpatent/CA2555051C/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Pyrrole Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
This invention provides compounds 3-[2-(4- benzyloxy-benzoyl)-5-methoxy-phenyl]-1-phenyl-propan-1-one and (4-benzyloxy-phenyl)-{4-methoxy-2-[2-(2-phenyl- [1,3]dioxolan-2-yl)-ethyl]-phenyl}-methanone, and a method of producing a compound of the formula: wherein R is a protected hydroxyl group or
CA002555051A1999-05-242000-05-19Process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine
Expired - LifetimeCA2555051C
(en)
Polymorphs of 2-methyl-2-[4-({[-4methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-carbonyl]-amino}-methyl)-phenoxy]-propionic acid, process for their preparation, their use and pharmaceurical compositions containing them
Preparation of 2-(2-fluoro-4-biphenyl) propionic acid enantiomers and the n-[4-(4-(methylthio)phenyl)-1, 3-dioxan-5-yl]-2-(2-fluoro-4-biphenyl)propionamide intermediate therefor
Novel chiral compounds derived from hexanoic acid esters, method and intermediate chemicals for the preparation and use thereof for synthesis of 2-(bromomethyl)2-ethyl hexanoic chiral acid